NOQIntelligence™
NOQIntelligence™ is the active data and analysis layer behind NoQuestionsAI. It is built to help teams compare a developing GRAS dossier against FDA-facing precedent, known review patterns, and the kinds of evidentiary issues that can slow or compromise a no-questions outcome.
GRAS dossier quality depends on more than assembling citations. It depends on whether the scientific basis is coherent, whether each section is supported by the correct evidence, and whether the submission anticipates the questions a reviewer may ask. NOQIntelligence™ is built around that operational reality.
NOQIntelligence™ is designed around the practical record of the GRAS process: public no-questions letters, notice summaries, ingredient identities, use conditions, scientific rationales, and reviewer-facing issues that recur across submissions.
NOQIntelligence™ maps dossier content against patterns associated with clarification requests, evidentiary gaps, exposure questions, specification ambiguity, manufacturing uncertainty, and unsupported safety conclusions.
Rather than treating each answer as isolated text, NOQIntelligence™ evaluates the developing dossier as an integrated regulatory document with dependencies across identity, manufacturing, specifications, exposure, safety, and history.
General-purpose AI can produce fluent regulatory language, but fluent language is not the same as a defensible GRAS dossier. NoQuestionsAI pairs structured drafting with NOQIntelligence™ so that the workflow is continuously grounded in precedent, section-specific evidence expectations, and review-oriented risk assessment.
The objective is not broad web search. The objective is controlled comparison against domain-specific material that reflects how GRAS notices are organized, supported, and reviewed.
A manufacturing claim, a specification limit, and a safety conclusion require different kinds of support. NOQIntelligence™ is structured to respect those distinctions during review and risk assessment.
NOQIntelligence™ emphasizes issues a regulatory reviewer may reasonably ask about: missing definitions, unclear use levels, weak bridging logic, insufficient exposure support, and unresolved uncertainty.
As additional source material, no-questions letters, precedent categories, and question patterns are added, NOQIntelligence™ becomes a more complete operational memory for GRAS dossier development.
NOQIntelligence™ supports a disciplined review loop: retrieve relevant precedent, assess section-level support, identify potential review friction, and translate those signals into actionable dossier improvements.
NOQIntelligence™ strengthens NoQuestionsAI for GRAS work by evaluating dossier development through the lens of precedent, evidentiary sufficiency, and likely FDA-facing questions. NoQuestionsAI uses that intelligence to support better regulatory decisions before submission pressure begins.
View Plans